TY - JOUR T1 - Epidemiology of 869,220 varicose vein surgeries over 12 years in Brazil: trends, costs and mortality rate JF - medRxiv DO - 10.1101/2021.08.03.21261223 SP - 2021.08.03.21261223 AU - Marcela Juliano Silva AU - Andressa Cristina Sposato Louzada AU - Marcelo Fiorelli Alexandrino da Silva AU - Maria Fernanda Cassino Portugal AU - Marcelo Passos Teivelis AU - Nelson Wolosker Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/25/2021.08.03.21261223.abstract N2 - Objectives to assess the total numbers of surgical procedures performed between 2008 and 2019 for the treatment of varicose veins in the Public Health System, which exclusively insures more than 160 million Brazilians, the distribution of surgeries over time, as well as its costs and mortality rates.Study design retrospective cross-sectional population-based studyMaterials and Methods public and open data referring to all surgeries to treat chronic venous disease between 2008 and 2019 were extracted from the database of the Brazilian Public Health System.Results In total, 869,220 surgeries were performed to treat chronic venous disease in public hospitals and outpatient clinics in Brazil, with an average rate of 4.5 surgeries per 10,000 inhabitants per year. From 2015 on, we observed a slight downward trend in the total number of procedures. The total amount reimbursed by the government was US$ 232,775,518.11. A total of 49 deaths were registered following varicose vein surgery, corresponding to a mortality rate of 0.0056%.Conclusions a total of 869,220 surgeries performed to treat chronic venous disease over twelve years, with an overall rate of 4.52 procedures per 10,000 inhabitants per year. The mortality rate was very low, 0.0056%.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of the Hospital Israelita Albert Einstein (CAAE: 35826320.2.0000.0071). All data provided by DATASUS and TabNet is open and anonymous. For this reason, the Institutional Council of Revision exempted informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available at DATASUS platformCVDChronic venous diseaseUSAUnited States of AmericaSUSBrazilian Public Health System ER -